These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16520662)

  • 1. Anti-tumor activity of Titanocene Y in xenografted Caki-1 tumors in mice.
    Fichtner I; Pampillón C; Sweeney NJ; Strohfeldt K; Tacke M
    Anticancer Drugs; 2006 Mar; 17(3):333-6. PubMed ID: 16520662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor activity of titanocene dichloride in xenografted human renal-cell carcinoma.
    Köpf-Maier P
    Anticancer Res; 1999; 19(1A):493-504. PubMed ID: 10226588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vitro anti-tumor activity studies of bridged and unbridged benzyl-substituted titanocenes.
    Kelter G; Sweeney NJ; Strohfeldt K; Fiebig HH; Tacke M
    Anticancer Drugs; 2005 Nov; 16(10):1091-8. PubMed ID: 16222151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor activity of Titanocene Y against freshly explanted human breast tumor cells and in xenografted MCF-7 tumors in mice.
    Beckhove P; Oberschmidt O; Hanauske AR; Pampillón C; Schirrmacher V; Sweeney NJ; Strohfeldt K; Tacke M
    Anticancer Drugs; 2007 Mar; 18(3):311-5. PubMed ID: 17264764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumour activity of [1,2-di(cyclopentadienyl)-1,2-di(p-N,N-dimethylaminophenyl)-ethanediyl] titanium dichloride in xenografted Ehrlich's ascites tumour.
    Valadares MC; Ramos AL; Rehmann FJ; Sweeney NJ; Strohfeldt K; Tacke M; Queiroz ML
    Eur J Pharmacol; 2006 Mar; 534(1-3):264-70. PubMed ID: 16513106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiproliferative activity of Titanocene Y against tumor colony-forming units.
    Oberschmidt O; Hanauske AR; Pampillón C; Sweeney NJ; Strohfeldt K; Tacke M
    Anticancer Drugs; 2007 Mar; 18(3):317-21. PubMed ID: 17264765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of vinorelbine and titanocene dichloride on human tumour xenografts in nude mice.
    Friedrich M; Villena-Heinsen C; Farnhammer C; Schmidt W
    Eur J Gynaecol Oncol; 1998; 19(4):333-7. PubMed ID: 9744720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bimetallic titanocene-gold phosphane complexes inhibit invasion, metastasis, and angiogenesis-associated signaling molecules in renal cancer.
    Elie BT; Fernández-Gallardo J; Curado N; Cornejo MA; Ramos JW; Contel M
    Eur J Med Chem; 2019 Jan; 161():310-322. PubMed ID: 30368130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor inhibition by titanocene complexes: influence upon two xenografted human lung carcinomas.
    Köpf-Maier P
    J Cancer Res Clin Oncol; 1987; 113(4):342-8. PubMed ID: 3036884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-proliferative activity and mechanism of action of titanocene dichloride.
    Christodoulou CV; Eliopoulos AG; Young LS; Hodgkins L; Ferry DR; Kerr DJ
    Br J Cancer; 1998 Jun; 77(12):2088-97. PubMed ID: 9649119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II trial of titanocene dichloride in advanced renal-cell carcinoma.
    Lümmen G; Sperling H; Luboldt H; Otto T; Rübben H
    Cancer Chemother Pharmacol; 1998; 42(5):415-7. PubMed ID: 9771957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pan-PI-3 kinase inhibitor SF1126 shows antitumor and antiangiogenic activity in renal cell carcinoma.
    Joshi S; Singh AR; Durden DL
    Cancer Chemother Pharmacol; 2015 Mar; 75(3):595-608. PubMed ID: 25578041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human ovarian cancer xenografts in nude mice: chemotherapy trials with paclitaxel, cisplatin, vinorelbine and titanocene dichloride.
    Villena-Heinsen C; Friedrich M; Ertan AK; Farnhammer C; Schmidt W
    Anticancer Drugs; 1998 Jul; 9(6):557-63. PubMed ID: 9877245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticancer activity and mode of action of titanocene C.
    Olszewski U; Claffey J; Hogan M; Tacke M; Zeillinger R; Bednarski PJ; Hamilton G
    Invest New Drugs; 2011 Aug; 29(4):607-14. PubMed ID: 20162321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent antitumor activity of a novel nucleoside analogue, BCH-4556 (beta-L-dioxolane-cytidine), in human renal cell carcinoma xenograft tumor models.
    Kadhim SA; Bowlin TL; Waud WR; Angers EG; Bibeau L; DeMuys JM; Bednarski K; Cimpoia A; Attardo G
    Cancer Res; 1997 Nov; 57(21):4803-10. PubMed ID: 9354442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repurposing the anti-malarial drug artesunate as a novel therapeutic agent for metastatic renal cell carcinoma due to its attenuation of tumor growth, metastasis, and angiogenesis.
    Jeong DE; Song HJ; Lim S; Lee SJ; Lim JE; Nam DH; Joo KM; Jeong BC; Jeon SS; Choi HY; Lee HW
    Oncotarget; 2015 Oct; 6(32):33046-64. PubMed ID: 26426994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor inhibition by titanocene complexes: influence on xenografted human adenocarcinomas of the gastrointestinal tract.
    Köpf-Maier P
    Cancer Chemother Pharmacol; 1989; 23(4):225-30. PubMed ID: 2924380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NGAL can alternately mediate sunitinib resistance in renal cell carcinoma.
    Yu DS; Wu CL; Ping SY; Huang YL; Shen KH
    J Urol; 2014 Aug; 192(2):559-66. PubMed ID: 24423438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dimethyl titanocene Y: a valuable precursor for libraries of cytotoxic titanocene derivatives.
    Immel TA; Martin JT; Dürr CJ; Groth U; Huhn T
    J Inorg Biochem; 2010 Aug; 104(8):863-7. PubMed ID: 20452674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel titanocene anti-cancer drugs and their effect on apoptosis and the apoptotic pathway in prostate cancer cells.
    O'Connor K; Gill C; Tacke M; Rehmann FJ; Strohfeldt K; Sweeney N; Fitzpatrick JM; Watson RW
    Apoptosis; 2006 Jul; 11(7):1205-14. PubMed ID: 16699961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.